AI-generated summary
The authors report an open-label pilot study of 28 patients with moderate to moderately severe facial acne treated with topical gold microparticles and diode laser pulses. After a single three-session regimen, 76% of 25 analyzed patients achieved at least a 40% reduction in acne lesion count at 12 weeks. The study had no control group and a small sample, so the authors describe the approach as showing promise rather than proven.
- Participants
- 28
- Who or what was studied
- Patients with moderate and moderately severe facial acne vulgaris, 18 males and 10 females, mean age 19.8 years
- Limits stated in the abstract
- Small open-label pilot study without a control group, with only 25 of 28 enrolled patients analyzed and just 9 patients in the two-regimen arm.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Primary outcome, Chromophore, Pilot study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.